Matches in Wikidata for { <http://www.wikidata.org/entity/Q66047154> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66047154 description "clinical trial" @default.
- Q66047154 description "ensayu clínicu" @default.
- Q66047154 description "klinisch onderzoek" @default.
- Q66047154 description "клінічне випробування" @default.
- Q66047154 name "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements" @default.
- Q66047154 name "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements" @default.
- Q66047154 type Item @default.
- Q66047154 label "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements" @default.
- Q66047154 label "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements" @default.
- Q66047154 prefLabel "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements" @default.
- Q66047154 prefLabel "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements" @default.
- Q66047154 P1132 Q66047154-90B082C4-2059-4AD4-9B41-D78FD1A9A3D8 @default.
- Q66047154 P1476 Q66047154-5C2120CC-F1A0-497A-9623-ED88D7836F8E @default.
- Q66047154 P17 Q66047154-1ED47C9F-A472-44CB-A7A1-155C10D01CD7 @default.
- Q66047154 P1813 Q66047154-81EDA6D4-B024-40AD-A099-5A2B53C97A15 @default.
- Q66047154 P2899 Q66047154-57057F37-FF0E-451E-BCAD-D90E793766A2 @default.
- Q66047154 P3098 Q66047154-B0E6D686-90F6-4B69-871F-67C61B34F235 @default.
- Q66047154 P31 Q66047154-8B9B9594-93DC-48F0-B1A1-2C8AC415C797 @default.
- Q66047154 P580 Q66047154-F20CF43B-4ABB-4E44-A78F-4FDFFEF64C8C @default.
- Q66047154 P582 Q66047154-3C12D3BC-7BE7-4257-8C2B-0CB64B6F1673 @default.
- Q66047154 P6099 Q66047154-25A15AB8-40E8-4724-9295-38515BAD61AA @default.
- Q66047154 P6099 Q66047154-4DC4D908-C593-43C4-BD42-1743D14D37CA @default.
- Q66047154 P8363 Q66047154-66D4FFEF-B353-4CB6-B9B7-6266E5CA776B @default.
- Q66047154 P1132 "+450" @default.
- Q66047154 P1476 "A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)" @default.
- Q66047154 P17 Q30 @default.
- Q66047154 P1813 "TRIDENT-1" @default.
- Q66047154 P2899 "+12" @default.
- Q66047154 P3098 "NCT03093116" @default.
- Q66047154 P31 Q30612 @default.
- Q66047154 P580 "2017-02-27T00:00:00Z" @default.
- Q66047154 P582 "2021-03-01T00:00:00Z" @default.
- Q66047154 P6099 Q42824440 @default.
- Q66047154 P6099 Q5452194 @default.
- Q66047154 P8363 Q78089383 @default.